525.87BMarket Cap39.35P/E (TTM)
118.920High117.321Low3.98MVolume118.790Open119.070Pre Close469.12MTurnover0.13%Turnover Ratio42.43P/E (Static)4.46BShares147.59352wk High31.29P/B376.44BFloat Cap89.51452wk Low1.36Dividend TTM3.19BShs Float147.593Historical High1.15%Div YieldTTM1.34%Amplitude-3.073Historical Low118.015Avg Price1Lot Size
Novo-Nordisk A/S Stock Forum
$NVIDIA (NVDA.US)$ $Duolingo (DUOL.US)$ $Novo-Nordisk A/S (NVO.US)$ $Goldman Sachs (GS.US)$ $Tesla (TSLA.US)$
Currently only 35 hands of option cash secure sell put strike 89.50 expiry in late December 2024
All cash remain in $CSOP USD Money Market Fund (SGXZ96797238.MF)$ and $Fullerton Fund - Fullerton SGD Liquidity Fund (SGXZ40088619.MF)$
All the best
loading...
loading...
Gapping up
$Bristol-Myers Squibb (BMY.US)$ Shares jumped 3.8% after the FDA approved Cobenfy as a new treatment for schizophrenia in adults, marking the first novel treatment for the mental disorder in several decades.
$Wynn Resorts (WYNN.US)$ Shares climbed 1.7% following an upgrade to overweight from equal weight by Morgan Stanley, which highlighted the company's strong fundamentals compared to its competitors...
$NVIDIA (NVDA.US)$ $Palantir (PLTR.US)$ $Taiwan Semiconductor (TSM.US)$ $Tesla (TSLA.US)$ $Netflix (NFLX.US)$ $Microsoft (MSFT.US)$ $Alphabet-C (GOOG.US)$ $Apple (AAPL.US)$ $TransMedics (TMDX.US)$ $Novo-Nordisk A/S (NVO.US)$ $Walmart (WMT.US)$ $Coinbase (COIN.US)$ $Roundhill Magnificent Seven ETF (MAGS.US)$ $Amazon (AMZN.US)$ $Meta Platforms (META.US)$ $Advanced Micro Devices (AMD.US)$ $Vanguard S&P 500 ETF (VOO.US)$ $SPDR S&P 500 ETF (SPY.US)$ $iShares Core S&P 500 ETF (IVV.US)$ $Invesco QQQ Trust (QQQ.US)$ $Invesco NASDAQ 100 ETF (QQQM.US)$
10 clinical trials to watch in the second half of 2024 | BioPharma Dive
No comment yet